ALLY THERAPEUTICS
Ally Therapeutics solves the immune response barriers for gene therapy. They are dedicated to solving the immune response issues that limit the safety and efficacy of in vivo gene therapies. It is backed by ARCH, Alta, and UCB Ventures. The company is a new biotech company based in Cambridge, Massachusetts, and was founded in 2018.
ALLY THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.allytx.com
Total Employee:
1+
Status:
Closed
Total Funding:
10 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Elicio Therapeutics
Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.
Endpoint Health
Precision Immunology Therapies
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Ovid Therapeutics
Ovid Therapeutic's purpose is to solve intractable medical problems.
SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company.
Tallac Therapeutics
Tallac Therapeutics offers next generation immunotherapies for cancer patients.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.allytx.com
- Host name: ec2-3-140-13-188.us-east-2.compute.amazonaws.com
- IP address: 3.140.13.188
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Ally Therapeutics"
Alloy's Drug Discovery Technologies & Services Roadmap
Jan 9, 2023 Alloy reinvests 100% of its revenue into innovation and access to innovation, a commitment that enables the organization to continuously improve upon and develop new technologies to support its partners’ ambitious drug …See details»
Alloy Therapeutics, Inc. | LinkedIn
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. From licensing our platforms, to working with …See details»
Alloy Therapeutics - Crunchbase Investor Profile
Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human …See details»
Working At Alloy Therapeutics: Company Overview and Culture
Mar 14, 2024 www.alloytx.com. Organization Type. Private. CEO. Errik Anderson. Social Media. Alloy Therapeutics is a biotech ecosystem company, facilitating affordable, non-exclusive …See details»
Media - Alloy Therapeutics
BOSTON, Mass., May 21st, 2024 – Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to biologics drug discovery platforms and services, announced today a licensing agreement for …See details»
Alloy Therapeutics CEO and Key Executive Team | Craft.co
Alloy Therapeutics's Founder, CEO, Chairman is Errik Anderson. Other executives include Logan Snyder, General Counsel; Jason Camm, Board Member and 4 others. See the full leadership …See details»
Alloy Therapeutics - Overview, News & Similar companies
View Alloy Therapeutics (www.alloytx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Alloy Therapeutics Unveils 2023 Innovation Roadmap …
Jan 9, 2023 Alloy reinvests 100% of its revenue into innovation and access to innovation, a commitment that enables the organization to continuously improve upon and develop new technologies to support its ...See details»
Alloy Therapeutics - VentureRadar
"Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we …See details»
Alloy Therapeutics Raises $42 Million in Series D Financing
Oct 3, 2022 The technologies and protocols can be replicated in a partner’s organization through a platform transfer and as part of an Alloy Innovation Subscription. Alloy is a leader in …See details»
Alloy Therapeutics Announces Platform License Agreement with Lilly
BOSTON, May 21, 2024--Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to biologics drug discovery platforms and services, announced today a …See details»
Making better medicines by breaking down barriers to translation
Alloytx.com Making better medicines by breaking down barriers to translation Alloy Therapeutics, a biotechnology ecosystem company, is committed to providing affordable and non-exclusive …See details»
Alloy Therapeutics to empower drug discovery of Lundbeck’s …
May 2, 2023 Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners …See details»
Alloy Therapeutics - workinbiotech.com
Alloy Therapeutics describes itself as a biotechnology ecosystem company that enables pre-competitive drug discovery at all levels. Alloy currently offers licensing in antibody and TCR …See details»
Alloy Therapeutics Acquires deepCDR Biologics to Bring …
Dec 9, 2021 Alloy Therapeutics, a biotechnology ecosystem company, announced it has acquired deepCDR Biologics, a Basel, Switzerland-based developer of deep learnSee details»
Keyway ™ TCR Discovery - Alloy Therapeutics
BOSTON, Mass., May 21st, 2024 – Alloy Therapeutics, a biotechnology ecosystem company dedicated to democratizing access to biologics drug discovery platforms and services, …See details»
Antibody Discovery Services and Technologies - Alloy Therapeutics
We started with the ATX-Gx transgenic humanized mice platform for antibody discovery and have built a robust discovery services organization around that foundational technology, while …See details»
Alloy Therapeutics and Pyxis Oncology Form Kyma ... - Business Wire
May 25, 2021 Alloy Media Contact Erin Glabets [email protected] Pyxis Investor Contact Ashley Robinson LifeSci Advisors, LLC [email protected] Pyxis Media Contact …See details»
ATX-Gx™ Humanized Transgenic Mice for Antibody Discovery
Organization. × Keyway TCR Mimic Discovery Webinar. Access the webinar recording. I’d like more material about Keyway TCR Discovery. Thanks for your interest in our recent Keyway …See details»